Pfizer debuts generic drug portfolio in the UK

The UK subsidiary of global drugs behemoth Pfizer has today launched six generic medicines for its pharmacy and dispensing customers. These drugs have been introduced into Pfizer's Established Products Business Unit portfolio of over 80 off-patent medicines, following agreements between Pfizer and generic medicine manufacturers Aurobindo Pharma and Claris Lifesciences last year, the firm noted.

The copy drugs in question are metformin, finasteride, ondansetron, paroxetine, mirtazapine and mirtazapine OD for disorders including, type 2 diabetes, benign prostatic hyperplasia, post-operative nausea and vomiting and depression, respectively.

The introduction of these medicines increases the range of high quality and cost effective medicine options that Pfizer can offer pharmacists and health care professionals, the company said adding that, over time, it plans to increase the range of generic medicines offered to its customers, with further medicines expected to be launched throughout this year.